Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Okairos AG

Division of GlaxoSmithKline PLC
www.okairos.com

Latest From Okairos AG

Boehringer Ingelheim Expands Oncolytic Virus Efforts With ViraTherapeutics Buy

Paying €210m for a company that only has preclinical programs may seem steep but BI is clearly impressed with the progress being made by its Austrian partner's lead candidate.

ImmunoOncology M & A

Boehringer's Expanded Venture Fund: Innovation First, Returns Second

Boehringer Ingelheim more than doubled its venture fund from €100m to €250m, giving BI more access to early innovation via new capital, two new investment managers and a West Coast presence.

Business Strategies Financing

NousCom Raises €42m For Novel Cancer Vaccines

European biotech NousCom is making ready two multi-neoantigen containing vaccines that with a new round of VC funding should enter clinical studies in 2018, and that it hopes to combine with checkpoint inhibitors.

Financing Cancer

Swiss VC Launches New Fund With Orphan Drug Aspirations

Basel-based BioMedPartners has launched a new CHF75m venture capital fund, BioMedInvest III, boosting financing opportunities for startups and mid-sized biotechs in the sparse European market.

Financing Commercial
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Okairos SRL
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • GlaxoSmithKline PLC
  • Senior Management
  • Riccardo Cortese, MD, PhD, CEO
    Alfredo Nicosia, PhD, CSO
  • Contact Info
  • Okairos AG
    Phone: (39) 06 97246470
    Elisabethenstrasse 3
    Basel, 4051
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register